Computational analysis of mRNA expression profiles identifies the ITG family and PIK3R3 as crucial genes for regulating triple negative breast cancer cell migration

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Klahan, Sukhontip ^a   Wu, Mei Shin ^a   Hsi, Edward ^b   Huang, Chi Cheng ^c,d,e,f   Hou, Ming Feng ^b,g   Chang, Wei Chiao ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; PROTEIN P53; SCATTER FACTOR; INTEGRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3R3 PROTEIN, HUMAN;

ACTIN FILAMENT; ADULT; ARTICLE; CANCER CELL; CANCER STAGING; CELL DEATH; CELL MATURATION; CELL MIGRATION; CELL MOTION; CELL SURVIVAL; DOWN REGULATION; GENE; GENE EXPRESSION PROFILING; GENE MAPPING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; ITGA6 GENE; ITGAL GENE; ITGB1 GENE; NUCLEOTIDE SEQUENCE; PIK3R3 GENE; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGY; COMPUTER PROGRAM; DATA MINING; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CELL MOVEMENT; COMPUTATIONAL BIOLOGY; DATA MINING; DEMOGRAPHY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; INTEGRINS; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOFTWARE; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84901801903     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/536591     Document Type: Article

References (39)

1. Ferlay J., Shin H.-R., Bray F., Forman D., Mathers C., Parkin D. M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010 127 12 2893 2917 2-s2.0-78049485263 10.1002/ijc.25516
2. Carey L., Winer E., Viale G., Cameron D., Gianni L., Triple-negative breast cancer: disease entity or title of convenience? Nature Reviews Clinical Oncology 2010 7 12 683 692 2-s2.0-78649663247 10.1038/nrclinonc.2010.154
3. Brouckaert O., Wildiers H., Floris G., Neven P., Update on triple-negative breast cancer: prognosis and management strategies. International Journal of Women's Health 2012 4 511 520
4. Heitz F., Harter P., Traut A., Lueck H. J., Beutel B., du Bois A., Cerebral metastases (CM) in breast cancer (BC) with focus on triple-negative tumors. Journal of Clinical Oncology 2008 26 15, supplement
5. Nielsen T. O., Hsu F. D., Jensen K., Cheang M., Karaca G., Hu Z., Hernandez-Boussard T., Livasy C., Cowan D., Dressler L., Akslen L. A., Ragaz J., Gown A. M., Gilks C. B., Van De Rijn M., Perou C. M., Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clinical Cancer Research 2004 10 16 5367 5374 2-s2.0-4143150688 10.1158/1078-0432.CCR-04-0220 (Pubitemid 39100473)
6. Tseng L. M., Hsu N. C., Chen S. C., Distant metastasis in triple-negative breast cancer. Neoplasma 2013 60 3 290 294 10.4149/neo-2013-038
7. Dent R., Trudeau M., Pritchard K. I., Hanna W. M., Kahn H. K., Sawka C. A., Lickley L. A., Rawlinson E., Sun P., Narod S. A., Triple-negative breast cancer: clinical features and patterns of recurrence. Clinical Cancer Research 2007 13 15, part 1 4429 4434 2-s2.0-34547661993 10.1158/1078-0432.CCR-06-3045 (Pubitemid 47219710)
8. Dent R., Hanna W. M., Trudeau M., Rawlinson E., Sun P., Narod S. A., Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Research and Treatment 2009 115 2 423 428 2-s2.0-67349148556 10.1007/s10549-008-0086-2
9. Haffty B. G., Yang Q., Reiss M., Kearney T., Higgins S. A., Weidhaas J., Harris L., Hait W., Toppmeyer D., Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. Journal of Clinical Oncology 2006 24 36 5652 5657 2-s2.0-34247381115 10.1200/JCO.2006.06. 5664 (Pubitemid 46631305)
10. Kennecke H., Yerushalmi R., Woods R., Cheang M. C. U., Voduc D., Speers C. H., Nielsen T. O., Gelmon K., Metastatic behavior of breast cancer subtypes. Journal of Clinical Oncology 2010 28 20 3271 3277 2-s2.0-77954740501 10.1200/JCO.2009.25.9820
11. Morris G. J., Naidu S., Topham A. K., Guiles F., Xu Y., McCue P., Schwartz G. F., Park P. K., Rosenberg A. L., Brill K., Mitchell E. P., Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the national cancer institute's surveillance, epidemiology, and end results database. Cancer 2007 110 4 876 884 2-s2.0-34547860028 10.1002/cncr.22836 (Pubitemid 47257667)
12. Lin N. U., Vanderplas A., Hughes M. E., Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer 2012 118 22 5463 5472
13. Yao-Lung K., Dar-Ren C., Tsai-Wang C., Clinicopathological features of triple-negative breast cancer in Taiwanese women. International Journal of Clinical Oncology 2011 16 5 500 505 2-s2.0-84857098861
14. Li C. Y., Zhang S., Zhang X. B., Wang P., Hou G. F., Zhang J., Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study. Asian Pacific Journal of Cancer Prevention 2013 14 6 3779 3784
15. Zygourakis K., Quantification and regulation of cell migration. Tissue Engineering 1996 2 1 1 16 2-s2.0-0029950107 (Pubitemid 26178009)
16. Jouanneau J., Bellusci S., Moens G., Thiery J. P., Molecular aspects of invasiveness and metastasis. Pathologie Biologie 1995 43 3 181 187 2-s2.0-0029261770
17. Lindner R., Sullivan C., Offor O., Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy. PLoS ONE 2013 8 11 e71915
18. Kuo W. H., Chang Y. Y., Lai L. C., Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas. PLoS ONE 2012 7 9 e45831
19. Whole-genome DASL HT assay for expression profiling in ffpe samples. http://res.illumina.com/documents/products/datasheets/datasheet-whole-genome- dasl.pdf
20. Agilent whole human genome oligo microarray kit. http://www.chem.agilent. com/library/brochures/5989-0654en-wghuman-7-04-web.pdf
21. American Joint Commitee on Cancer,. https://cancerstaging.org
22. Tusher V. G., Tibshirani R., Chu G., Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5116 5121 2-s2.0-0035942271 10.1073/pnas.091062498 (Pubitemid 32397092)
23. Huang D. W., Sherman B. T., Lempicki R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009 4 1 44 57 2-s2.0-61449172037 10.1038/nprot.2008.211
24. Castellana B., Escuin D., Peiro G., ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas. Journal of Cancer 2012 3 175 183 10.7150/jca.4120
25. Epping M. T., Wang L., Edel M. J., Carlée L., Hernandez M., Bernards R., The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 2005 122 6 835 847 2-s2.0-25144503301 10.1016/j.cell.2005.07.003 (Pubitemid 41345202)
26. Rodriguez-Mari A., Canestro C., BreMiller R. A., Catchen J. M., Yan Y. L., Postlethwait J. H., Retinoic acid metabolic genes, meiosis, and gonadal sex differentiation in zebrafish. PLoS ONE 2013 8 9 e73951
27. Ivanova I. A., Vermeulen J. F., Ercan C., FER kinase promotes breast cancer metastasis by regulating alpha6- and beta1-integrin-dependent cell adhesion and anoikis resistance. Oncogene 2013 32 50 5582 5592
28. Barkan D., Chambers A. F., β 1-integrin: a potential therapeutic target in the battle against cancer recurrence. Clinical Cancer Research 2011 17 23 7219 7223 2-s2.0-82555189403 10.1158/1078-0432.CCR-11-0642
29. Sredni B., Immunomodulating tellurium compounds as anti-cancer agents. Seminars in Cancer Biology 2012 22 1 60 69 2-s2.0-84857140120 10.1016/j.semcancer.2011.12.003
30. Velasco-Velázquez M. A., Salinas-Jazmín N., Mendoza-Patiño N., Mandoki J. J., Reduced paxillin expression contributes to the antimetastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells. Cancer Cell International 2008 8, article 8 2-s2.0-45749148244 10.1186/1475-2867-8-8
31. Mizejewski G. J., Role of integrins in cancer: survey of expression patterns. Proceedings of the Society for Experimental Biology and Medicine 1999 222 2 124 138 2-s2.0-0032721665
32. Nagore E., Montoro A., García-Casado Z., Botella-Estrada R., Insa A., Lluch A., López-Guerrero J. A., Guillén C., Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer. Melanoma Research 2009 19 4 211 214 2-s2.0-70349916132 10.1097/CMR. 0b013e3283281057
33. El-Attar H. A., Sheta M. I., Hepatocyte growth factor profile with breast cancer. Indian Journal of Pathology and Microbiology 2011 54 3 509 513 2-s2.0-80053901842 10.4103/0377-4929.85083
34. Sheen-Chen S.-M., Liu Y.-W., Eng H.-L., Chou F.-F., Serum levels of hepatocyte growth factor in patients with breast cancer. Cancer Epidemiology Biomarkers and Prevention 2005 14 3 715 717 2-s2.0-16844362951 10.1158/1055-9965.EPI-04-0340 (Pubitemid 40489220)
35. Kramer A., Green J., Pollard J. Jr., Tugendreich S., Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 2014 30 523 530
36. Xu L., Wen Z., Zhou Y., MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway. Molecular Biology of the Cell 2013 24 1 42 55
37. Kong X., Li G., Yuan Y., MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS ONE 2012 7 8 e41523
38. Hyun S., Lee J. H., Jin H., Nam J., Namkoong B., Lee G., Chung J., Kim V. N., Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. Cell 2009 139 6 1096 1108 2-s2.0-71149108895 10.1016/j.cell.2009.11.020
39. Ausprunk D. H., Folkman J., Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvascular Research 1977 14 1 53 65 2-s2.0-0017370183 (Pubitemid 8153798)